Cutis; cutaneous medicine for the practitioner 2011-01-01

Unilateral eyelid angioedema with congestion of the right bulbar conjunctiva due to loxoprofen sodium.

Daisuke Tsuruta, Tomoko Oshimo, Junko Sowa, Masamitsu Ishii, Hiromi Kobayashi

Index: Cutis. 87(1) , 41-3, (2011)

Full Text: HTML

Abstract

Angioedema is a variant of urticaria that causes deep dermal and subcutaneous swelling. It frequently is a unilateral reaction and usually lasts for several hours but may persist for several days. We report 2 cases of angioedema that involved the right upper and lower eyelids and was associated with congestion of the right bulbar conjunctiva; the symptoms started approximately 1 to 2 hours after taking loxoprofen sodium. All of the symptoms subsided after oral corticosteroid therapy. In both cases, an oral challenge test with 60 mg of loxoprofen sodium (contained in a tablet) caused swelling of the right upper eyelid within several hours, followed by swelling of the right bulbar conjunctiva. We believe the drug reaction in both patients is angioedema.


Related Compounds

Related Articles:

Determination of nonsteroidal anti-inflammatory drugs in human tear and plasma samples using ultra-fast liquid chromatography-tandem mass spectrometry.

2015-09-01

[Jpn. J. Ophthalmol. 59 , 364-71, (2015)]

Risk of peptic ulcer bleeding associated with Helicobacter pylori infection, nonsteroidal anti-inflammatory drugs, low-dose aspirin, and antihypertensive drugs: a case-control study.

2015-02-01

[J. Gastroenterol. Hepatol. 30(2) , 292-8, (2015)]

Effect of X-ray exposure on the pharmaceutical quality of drug tablets using X-ray inspection equipment.

2015-06-01

[Drug Dev. Ind. Pharm. 41 , 953-8, (2015)]

Influence of nonsteroidal anti-inflammatory drugs on the antiplatelet effects of aspirin in rats.

2011-01-01

[Biol. Pharm. Bull. 34(2) , 233-7, (2011)]

Protective effect of geranylgeranylacetone against loxoprofen sodium-induced small intestinal lesions in rats.

2011-02-10

[Eur. J. Pharmacol. 652(1-3) , 121-5, (2011)]

More Articles...